Exciting Phase 2 Results from the ARINA-1 Trial!!

Hi Everyone,

CLINICAL TRIAL UPDATE✨✨
GREAT NEWS ABOUT ARINA-1 nebulizing therapy clinical trial (NOT AN ANTIBIOTIC)!!

Were you in the trial? If so, thank you!!! ✨✨

"These results highlight the important role that ARINA-1 could play in the treatment of non-CF bronchiectasis and are extremely encouraging for patients," said Charles Daley, MD, Professor and Chief, Division of Mycobacterial & Respiratory Infections at National Jewish Health in Denver, Colorado.

"ARINA-1’s novel mechanism improved quality of life and also improved mucus biomarkers in people with bronchiectasis," said Carolyn Durham, PhD, Chief Scientific Officer of Renovion.

"The quality of life data confirms that improving mucus biomarkers, such as viscosity and NE (neutrophil elastase) can reduce symptoms and also improve patient outcomes in this underserved patient population.

These data provide a strong rationale for the continued development of ARINA-1 for NCFBE patients, as well as other populations that suffer from mucus symptoms. We look forward to further analyzing the data and discussing next steps with regulatory authorities."
https://tinyurl.com/yskwez7n
Renovion will discuss study results at the American Thoracic Society Meeting (May 17-22) and present findings at the World Bronchiectasis Conference (July 4-6) in Dundee, Scotland.
Excerpts from BusinessWire April 30th

Warm regards,
Linda Esposito

PS- What's better than sharing good news?